Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Short report

Role of adhesion molecules and inflammation in Venezuelan equine encephalitis virus infected mouse brain

Authors: Anuj Sharma, Manish Bhomia, Shelley P Honnold, Radha K Maheshwari

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Neuroinvasion of Venezuelan equine encephalitis virus (VEEV) and subsequent initiation of inflammation in the brain plays a crucial role in the outcome of VEEV infection in mice. Adhesion molecules expressed on microvascular endothelial cells in the brain have been implicated in the modulation of the blood brain barrier (BBB) and inflammation in brain but their role in VEEV pathogenesis is not very well understood. In this study, we evaluated the expression of extracellular matrix and adhesion molecules genes in the brain of VEEV infected mice.

Findings

Several cell to cell adhesion molecules and extracellular matrix protein genes such as ICAM-1, VCAM-1, CD44, Cadherins, integrins, MMPs and Timp1 were differentially regulated post-VEEV infection. ICAM-1 knock-out (IKO) mice infected with VEEV had markedly reduced inflammation in the brain and demonstrated a delay in the onset of clinical symptoms of disease. A differential regulation of inflammatory genes was observed in the IKO mice brain compared to their WT counterparts.

Conclusions

These results improve our present understanding of VEEV induced inflammation in mouse brain.
Appendix
Available only for authorised users
Literature
1.
go back to reference Charles PC, Trgovcich J, Davis NL, Johnston RE: Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology 2001,284(2):190-202. 10.1006/viro.2001.0878CrossRefPubMed Charles PC, Trgovcich J, Davis NL, Johnston RE: Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse. Virology 2001,284(2):190-202. 10.1006/viro.2001.0878CrossRefPubMed
2.
go back to reference Ryzhikov AB, Ryabchikova EI, Sergeev AN, Tkacheva NV: Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch Virol 1995,140(12):2243-2254. 10.1007/BF01323243CrossRefPubMed Ryzhikov AB, Ryabchikova EI, Sergeev AN, Tkacheva NV: Spread of Venezuelan equine encephalitis virus in mice olfactory tract. Arch Virol 1995,140(12):2243-2254. 10.1007/BF01323243CrossRefPubMed
3.
go back to reference Eugenin EA, Berman JW: Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 2003,29(4):351-361. 10.1016/S1046-2023(02)00359-6CrossRefPubMed Eugenin EA, Berman JW: Chemokine-dependent mechanisms of leukocyte trafficking across a model of the blood-brain barrier. Methods 2003,29(4):351-361. 10.1016/S1046-2023(02)00359-6CrossRefPubMed
4.
go back to reference Sharma A, Bhattacharya B, Puri RK, Maheshwari RK: Venezuelan equine encephalitis virus infection causes modulation of inflammatory and immune response genes in mouse brain. BMC Genomics 2008, 9: 289. 10.1186/1471-2164-9-289PubMedCentralCrossRefPubMed Sharma A, Bhattacharya B, Puri RK, Maheshwari RK: Venezuelan equine encephalitis virus infection causes modulation of inflammatory and immune response genes in mouse brain. BMC Genomics 2008, 9: 289. 10.1186/1471-2164-9-289PubMedCentralCrossRefPubMed
5.
go back to reference Sharma A, Maheshwari RK: Oligonucleotide Array Analysis of Toll Like Receptors and Associated Signaling Genes in Venezuelan Equine Encephalitis Virus Infected Mouse Brain. J Gen Virol 2009,90(Pt 8):1836-47.CrossRefPubMed Sharma A, Maheshwari RK: Oligonucleotide Array Analysis of Toll Like Receptors and Associated Signaling Genes in Venezuelan Equine Encephalitis Virus Infected Mouse Brain. J Gen Virol 2009,90(Pt 8):1836-47.CrossRefPubMed
6.
go back to reference Dallasta LM, Wang G, Bodnar RJ, Draviam R, Wiley CA, Achim CL, Hamilton RL: Differential expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in chronic murine retroviral encephalitis. Neuropathol Appl Neurobiol 2000,26(4):332-341. 10.1046/j.1365-2990.2000.00249.xCrossRefPubMed Dallasta LM, Wang G, Bodnar RJ, Draviam R, Wiley CA, Achim CL, Hamilton RL: Differential expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in chronic murine retroviral encephalitis. Neuropathol Appl Neurobiol 2000,26(4):332-341. 10.1046/j.1365-2990.2000.00249.xCrossRefPubMed
7.
go back to reference Mueller KL, Daniels MA, Felthauser A, Kao C, Jameson SC, Shimizu Y: Cutting edge: LFA-1 integrin-dependent T cell adhesion is regulated by both ag specificity and sensitivity. J Immunol 2004,173(4):2222-2226.CrossRefPubMed Mueller KL, Daniels MA, Felthauser A, Kao C, Jameson SC, Shimizu Y: Cutting edge: LFA-1 integrin-dependent T cell adhesion is regulated by both ag specificity and sensitivity. J Immunol 2004,173(4):2222-2226.CrossRefPubMed
8.
go back to reference Schafer A, Whitmore AC, Konopka JL, Johnston RE: Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. J Virol 2009,83(9):4275-4286. 10.1128/JVI.02383-08PubMedCentralCrossRefPubMed Schafer A, Whitmore AC, Konopka JL, Johnston RE: Replicon particles of Venezuelan equine encephalitis virus as a reductionist murine model for encephalitis. J Virol 2009,83(9):4275-4286. 10.1128/JVI.02383-08PubMedCentralCrossRefPubMed
9.
go back to reference Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003,4(5):P3. 10.1186/gb-2003-4-5-p3CrossRefPubMed Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003,4(5):P3. 10.1186/gb-2003-4-5-p3CrossRefPubMed
10.
go back to reference Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1):44-57.CrossRefPubMed Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009,4(1):44-57.CrossRefPubMed
11.
go back to reference Dai J, Wang P, Bai F, Town T, Fikrig E: Icam-1 participates in the entry of west nile virus into the central nervous system. J Virol 2008,82(8):4164-4168. 10.1128/JVI.02621-07PubMedCentralCrossRefPubMed Dai J, Wang P, Bai F, Town T, Fikrig E: Icam-1 participates in the entry of west nile virus into the central nervous system. J Virol 2008,82(8):4164-4168. 10.1128/JVI.02621-07PubMedCentralCrossRefPubMed
12.
go back to reference Soilu-Hanninen M, Roytta M, Salmi AA, Salonen R: Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium. J Neurovirol 1997,3(5):350-360. 10.3109/13550289709030749CrossRefPubMed Soilu-Hanninen M, Roytta M, Salmi AA, Salonen R: Semliki Forest virus infection leads to increased expression of adhesion molecules on splenic T-cells and on brain vascular endothelium. J Neurovirol 1997,3(5):350-360. 10.3109/13550289709030749CrossRefPubMed
13.
go back to reference Drescher KM, Zoecklein LJ, Rodriguez M: ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination. J Neurovirol 2002,8(5):452-458. 10.1080/13550280260422767CrossRefPubMed Drescher KM, Zoecklein LJ, Rodriguez M: ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination. J Neurovirol 2002,8(5):452-458. 10.1080/13550280260422767CrossRefPubMed
14.
go back to reference Christensen JP, Marker O, Thomsen AR: T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice. J Virol 1996,70(12):8997-9002.PubMedCentralPubMed Christensen JP, Marker O, Thomsen AR: T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice. J Virol 1996,70(12):8997-9002.PubMedCentralPubMed
15.
go back to reference Kyrkanides S, Miller AW, Miller JN, Tallents RH, Brouxhon SM, Olschowka ME, O'Banion MK, Olschowka JA: Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-/- mouse model of neurodegeneration. J Neuroimmunol 2008,203(1):50-57. 10.1016/j.jneuroim.2008.06.024PubMedCentralCrossRefPubMed Kyrkanides S, Miller AW, Miller JN, Tallents RH, Brouxhon SM, Olschowka ME, O'Banion MK, Olschowka JA: Peripheral blood mononuclear cell infiltration and neuroinflammation in the HexB-/- mouse model of neurodegeneration. J Neuroimmunol 2008,203(1):50-57. 10.1016/j.jneuroim.2008.06.024PubMedCentralCrossRefPubMed
16.
go back to reference Genovese T, Esposito E, Mazzon E, Di Paola R, Caminiti R, Bramanti P, Cappelani A, Cuzzocrea S: Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 2009,108(6):1360-1372. 10.1111/j.1471-4159.2009.05899.xCrossRefPubMed Genovese T, Esposito E, Mazzon E, Di Paola R, Caminiti R, Bramanti P, Cappelani A, Cuzzocrea S: Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 2009,108(6):1360-1372. 10.1111/j.1471-4159.2009.05899.xCrossRefPubMed
17.
go back to reference Marques CP, Hu S, Sheng W, Cheeran MC, Cox D, Lokensgard JR: Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia 2004,47(4):358-366. 10.1002/glia.20045CrossRefPubMed Marques CP, Hu S, Sheng W, Cheeran MC, Cox D, Lokensgard JR: Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia 2004,47(4):358-366. 10.1002/glia.20045CrossRefPubMed
18.
go back to reference Wahl C, Wegenka UM, Leithauser F, Schirmbeck R, Reimann J: IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency. J Immunol 2009,182(8):4521-4528. 10.4049/jimmunol.0802810CrossRefPubMed Wahl C, Wegenka UM, Leithauser F, Schirmbeck R, Reimann J: IL-22-dependent attenuation of T cell-dependent (ConA) hepatitis in herpes virus entry mediator deficiency. J Immunol 2009,182(8):4521-4528. 10.4049/jimmunol.0802810CrossRefPubMed
19.
go back to reference Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA: A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 2005,165(1-2):63-74. 10.1016/j.jneuroim.2005.04.018CrossRefPubMed Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA: A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol 2005,165(1-2):63-74. 10.1016/j.jneuroim.2005.04.018CrossRefPubMed
20.
go back to reference Eltayeb S, Berg AL, Lassmann H, Wallstrom E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D: Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflammation 2007, 4: 14. 10.1186/1742-2094-4-14PubMedCentralCrossRefPubMed Eltayeb S, Berg AL, Lassmann H, Wallstrom E, Nilsson M, Olsson T, Ericsson-Dahlstrand A, Sunnemark D: Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. J Neuroinflammation 2007, 4: 14. 10.1186/1742-2094-4-14PubMedCentralCrossRefPubMed
21.
go back to reference Franciotta D, Zardini E, Ravaglia S, Piccolo G, Andreoni L, Bergamaschi R, Romani A, Tavazzi E, Naldi P, Ceroni M, et al.: Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci 2006,247(2):202-207. 10.1016/j.jns.2006.05.049CrossRefPubMed Franciotta D, Zardini E, Ravaglia S, Piccolo G, Andreoni L, Bergamaschi R, Romani A, Tavazzi E, Naldi P, Ceroni M, et al.: Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J Neurol Sci 2006,247(2):202-207. 10.1016/j.jns.2006.05.049CrossRefPubMed
22.
go back to reference Kim BO, Liu Y, Zhou BY, He JJ: Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein. J Immunol 2004,172(3):1888-1895.CrossRefPubMed Kim BO, Liu Y, Zhou BY, He JJ: Induction of C chemokine XCL1 (lymphotactin/single C motif-1 alpha/activation-induced, T cell-derived and chemokine-related cytokine) expression by HIV-1 Tat protein. J Immunol 2004,172(3):1888-1895.CrossRefPubMed
23.
go back to reference Trebst C, Staugaitis SM, Tucky B, Wei T, Suzuki K, Aldape KD, Pardo CA, Troncoso J, Lassmann H, Ransohoff RM: Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol Appl Neurobiol 2003,29(6):584-595. 10.1046/j.0305-1846.2003.00507.xCrossRefPubMed Trebst C, Staugaitis SM, Tucky B, Wei T, Suzuki K, Aldape KD, Pardo CA, Troncoso J, Lassmann H, Ransohoff RM: Chemokine receptors on infiltrating leucocytes in inflammatory pathologies of the central nervous system (CNS). Neuropathol Appl Neurobiol 2003,29(6):584-595. 10.1046/j.0305-1846.2003.00507.xCrossRefPubMed
Metadata
Title
Role of adhesion molecules and inflammation in Venezuelan equine encephalitis virus infected mouse brain
Authors
Anuj Sharma
Manish Bhomia
Shelley P Honnold
Radha K Maheshwari
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-197

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine